Nonagen is a spin-off of Drs. Charles J. Rosser's and Steve Goodison's (Oxford University graduated) academic laboratories. Dr. Rosser is an accomplished translational physician-scientist and Dr. Goodison is a world-renowned cancer molecular biologist who is currently Professor at Mayo Clinic. Together, they have amassed over $21M which has been used for the discovery, early validation and late validation of the suite of Oncuria tests.